Effect of eplerenone on choroidal blood flow changes during isometric exercise in patients with chronic central serous chorioretinopathy

Acta Ophthalmol. 2021 Dec;99(8):e1375-e1381. doi: 10.1111/aos.14809. Epub 2021 Mar 1.

Abstract

Purpose: To investigate choroidal blood flow changes after isometric exercise in patients with chronic central serous chorioretinopathy nontreated or treated with mineralocorticoid receptor antagonists (MRA).

Methods: Foveolar choroidal laser Doppler flowmetry parameters - velocity (ChVel), volume (ChVol) and blood flow (ChBF) - of 22 eyes of 22 treated patients, 16 eyes of 16 untreated patients and 19 healthy controls were measured during a squatting test. Treatment consisted in MRA administration (eplerenone 50 mg/day or spironolactone 50 mg/day). The experiment comprised three successive periods: 30 seconds of rest, 2 min of continuous squatting exercise, and 150 seconds of recovery. Significance levels were calculated using a generalized estimating equation.

Results: During the squatting period, nontreated CSCR eyes had a similar change in ChVel (p = 0.8), ChVol (p = 0.8), ChBF (p = 0.5) and resistance to healthy eyes. Treated CSCR eyes exhibited significantly smaller changes in ChVel (-0.1 ± 11%, p = 0.04) than healthy eyes (6 ± 8%). No significant difference was found for ChVol and ChBF between the groups. The increase in ChVol from baseline in the nontreated CSCR group (4.4 ± 9%) was lower than that of treated group (6.7%±11%; p = 0.01). Finally, ChBF and ChVel changes in the CSCR groups were not significantly different.

Conclusions: No abnormalities were detected in the changes in ChBF parameters during increased ocular perfusion pressure in nontreated CSCR patients compared with controls. MRA treatment in CSCR patients induced a significant reduction in ChBVel and an increase in ChBVol in response to isometric exercise, suggesting that MRA exerts effects on choroidal vascular changes.

Keywords: blood supply; choroid; chronic central serous chorioretinopathy; imaging method; ocular perfusion pressure.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Central Serous Chorioretinopathy / diagnosis
  • Central Serous Chorioretinopathy / drug therapy*
  • Central Serous Chorioretinopathy / physiopathology
  • Choroid / blood supply*
  • Choroid / diagnostic imaging
  • Chronic Disease
  • Eplerenone / pharmacology*
  • Exercise / physiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Laser-Doppler Flowmetry
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists / pharmacology
  • Prospective Studies
  • Regional Blood Flow / drug effects*
  • Tomography, Optical Coherence / methods

Substances

  • Mineralocorticoid Receptor Antagonists
  • Eplerenone